Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAAS.
Cetin Gedik K, Ortega-Villa AM, Materne G, Rastegar A, Montealegre Sanchez GA, Reinhardt A, Brogan PA, Berkun Y, Murias S, Robles M, Schalm S, de Jesus AA, Goldbach-Mansky R.
Cetin Gedik K, et al. Among authors: materne g.
Ann Rheum Dis. 2024 Aug 27;83(9):1181-1188. doi: 10.1136/ard-2023-225463.
Ann Rheum Dis. 2024.
PMID: 38653530
Free PMC article.